Emily P. McCann

2.4k total citations
18 papers, 508 citations indexed

About

Emily P. McCann is a scholar working on Neurology, Genetics and Neurology. According to data from OpenAlex, Emily P. McCann has authored 18 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 8 papers in Genetics and 8 papers in Neurology. Recurrent topics in Emily P. McCann's work include Amyotrophic Lateral Sclerosis Research (14 papers), Neurological diseases and metabolism (8 papers) and Neurogenetic and Muscular Disorders Research (8 papers). Emily P. McCann is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (14 papers), Neurological diseases and metabolism (8 papers) and Neurogenetic and Muscular Disorders Research (8 papers). Emily P. McCann collaborates with scholars based in Australia, United Kingdom and New Zealand. Emily P. McCann's co-authors include Kelly L. Williams, Ian P. Blair, Jennifer A. Fifita, Garth A. Nicholson, Dominic B. Rowe, Andrew Colley, Naomi L. Bowers, Kristin Hadfield, Trine Prescott and Andrew J. Wallace and has published in prestigious journals such as Scientific Reports, Human Molecular Genetics and Frontiers in Immunology.

In The Last Decade

Emily P. McCann

16 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily P. McCann Australia	12	373	213	156	115	89	18	508
Paola Origone Italy	16	353 0.9×	190 0.9×	153 1.0×	46 0.4×	73 0.8×	47	584
Mariangela Mastrapasqua Italy	11	208 0.6×	154 0.7×	120 0.8×	22 0.2×	51 0.6×	19	432
Daniel H. Paushter United States	9	368 1.0×	171 0.8×	126 0.8×	103 0.9×	87 1.0×	12	639
Ching‐Hua Lu United Kingdom	9	252 0.7×	156 0.7×	169 1.1×	22 0.2×	61 0.7×	9	374
Lina Benajiba France	11	233 0.6×	167 0.8×	185 1.2×	23 0.2×	76 0.9×	33	549
Takuto Hideyama Japan	13	466 1.2×	644 3.0×	223 1.4×	38 0.3×	52 0.6×	38	913
J Rafałowska Poland	12	188 0.5×	137 0.6×	101 0.6×	21 0.2×	82 0.9×	44	390
D. Schiffer Italy	12	129 0.3×	158 0.7×	113 0.7×	38 0.3×	73 0.8×	34	399
Dayami Hernandez United States	6	274 0.7×	260 1.2×	165 1.1×	21 0.2×	69 0.8×	7	597
Joshua Menke United States	7	320 0.9×	63 0.3×	47 0.3×	40 0.3×	95 1.1×	20	504

Countries citing papers authored by Emily P. McCann

Since Specialization

Citations

This map shows the geographic impact of Emily P. McCann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily P. McCann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily P. McCann more than expected).

Fields of papers citing papers by Emily P. McCann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily P. McCann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily P. McCann. The network helps show where Emily P. McCann may publish in the future.

Co-authorship network of co-authors of Emily P. McCann

This figure shows the co-authorship network connecting the top 25 collaborators of Emily P. McCann. A scholar is included among the top collaborators of Emily P. McCann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily P. McCann. Emily P. McCann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Rodrigues, Miriam, Chitra Vinnakota, Christina M. Buchanan, et al.. (2025). The genetics of motor neuron disease in New Zealand. Journal of the Neurological Sciences. 474. 123472–123472.

McCann, Emily P., Natalie Grima, Jennifer A. Fifita, et al.. (2023). Characterising the Genetic Landscape of Amyotrophic Lateral Sclerosis: A Catalogue and Assessment of Over 1,000 Published Genetic Variants. Journal of Neuromuscular Diseases. 10(6). 1127–1141. 4 indexed citations

McCann, Emily P., et al.. (2022). Genetic determinants of antimicrobial resistance in three multi-drug resistant strains of Cutibacterium acnes isolated from patients with acne: a predictive in silico study. Access Microbiology. 4(8). 7 indexed citations

McCann, Emily P., Kelly L. Williams, Lyndal Henden, et al.. (2021). Genetic analysis of GLT8D1 and ARPP21 in Australian familial and sporadic amyotrophic lateral sclerosis. Neurobiology of Aging. 101. 297.e9–297.e11. 6 indexed citations

Fifita, Jennifer A., Emily P. McCann, Kelly L. Williams, et al.. (2021). Genetic Analysis of Tryptophan Metabolism Genes in Sporadic Amyotrophic Lateral Sclerosis. Frontiers in Immunology. 12. 701550–701550. 12 indexed citations

Henden, Lyndal, Natalie A. Twine, Emily P. McCann, et al.. (2020). Identity by descent analysis identifies founder events and links SOD1 familial and sporadic ALS cases. npj Genomic Medicine. 5(1). 32–32. 14 indexed citations

McCann, Emily P., Lyndal Henden, Jennifer A. Fifita, et al.. (2020). Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis. Journal of Medical Genetics. 58(2). 87–95. 57 indexed citations

Tarr, Ingrid, Emily P. McCann, Beben Benyamin, et al.. (2019). Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression. Scientific Reports. 9(1). 8254–8254. 30 indexed citations

Yang, Shu, et al.. (2019). Theme 3 In vitro experimental models. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 20(sup1). 135–159.

10.

Carey, John & Emily P. McCann. (2019). Lipase-Catalyzed Regioselective Ester Hydrolysis as a Key Step in an Alternative Synthesis of a Buprenorphine Pro-Drug. Organic Process Research & Development. 23(5). 771–774. 11 indexed citations

11.

McCann, Emily P., Kelly L. Williams, Jennifer A. Fifita, et al.. (2017). The genotype–phenotype landscape of familial amyotrophic lateral sclerosis in Australia. Clinical Genetics. 92(3). 259–266. 50 indexed citations

12.

Fifita, Jennifer A., Katharine Y. Zhang, Jasmin Galper, et al.. (2017). Genetic and Pathological Assessment of hnRNPA1, hnRNPA2/B1, and hnRNPA3 in Familial and Sporadic Amyotrophic Lateral Sclerosis. Neurodegenerative Diseases. 17(6). 304–312. 24 indexed citations

13.

Lovicu, Frank J., Daisy Y. Shu, Stephen Reddel, et al.. (2017). Postnatal Development of Spasticity Following Transgene Insertion in the Mouse βIV Spectrin Gene (SPTBN4). Journal of Neuromuscular Diseases. 4(2). 159–164. 1 indexed citations

14.

Fifita, Jennifer A., Kelly L. Williams, Vinod Sundaramoorthy, et al.. (2016). A novel amyotrophic lateral sclerosis mutation in OPTN induces ER stress and Golgi fragmentation in vitro. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 18(1-2). 126–133. 27 indexed citations

15.

Williams, Kelly L., Emily P. McCann, Jennifer A. Fifita, et al.. (2015). Novel TBK1 truncating mutation in a familial amyotrophic lateral sclerosis patient of Chinese origin. Neurobiology of Aging. 36(12). 3334.e1–3334.e5. 33 indexed citations

16.

Sundaramoorthy, Vinod, Adam K. Walker, Vanessa Tan, et al.. (2015). Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis. Human Molecular Genetics. 24(13). 3830–3846. 81 indexed citations

17.

Fifita, Jennifer A., Kelly L. Williams, Emily P. McCann, et al.. (2014). Mutation analysis of MATR3 in Australian familial amyotrophic lateral sclerosis. Neurobiology of Aging. 36(3). 1602.e1–1602.e2. 16 indexed citations

18.

Hadfield, Kristin, William G. Newman, Naomi L. Bowers, et al.. (2008). Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. Journal of Medical Genetics. 45(6). 332–339. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact